Impact of pharmaceutical care on hospital readmissions for heart failure: a randomised trial
Continuous care and follow-up by the pharmacist 30 days after discharge has a neutral impact on hospital readmissions and visits to the emergency department of patients with heart failure, but it is positive in the 90 days following discharge.
Authors
- Luis M. Bedoya
- Eduardo González Ferrer (ORCID: https://orcid.org/0000-0003-0428-6782)
- Beatriz Montero-Llorente (ORCID: https://orcid.org/0000-0002-9909-665X)
- C. Pérez Menéndez-Conde (ORCID: https://orcid.org/0000-0002-7785-0818)
- T. Bermejo Vicedo
- G. Castellanos
Institutions
- Universidad Complutense de Madrid (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Hospital Universitario Ramón y Cajal (ES)
Publication Details
- Journal
- European Journal of Hospital Pharmacy
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1136/ejhpharm-2024-004218
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00